Qiong Shou

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables	2014	Zhiwei Jiang Yang Song Qiong Shou Jielai Xia William Yang Wang

Common Coauthors

Coauthor	Papers Together
Yang Song	1
Jielai Xia	1
Zhiwei Jiang	1
William Yang Wang	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.	2007	Marissa Lassere Kent Johnson Maarten Boers Peter Tugwell Peter Brooks Lee S. Simon Vibeke Strand Philip G. Conaghan Mikkel Østergaard Walter P. Maksymowych	1
+	Statistical Principles for Clinical Trials	1998	Robert R. Kay	1
+	Surrogate endpoints: A basis for a rational approach	1992	Jean‐Pierre Boissel Jean‐Philippe Collet P Moleur M. Haugh	1
+	Hierarchical polytomous regression models with applications to health services research	1997	Michael J. Daniels Constantine Gatsonis	1
+ PDF Chat	Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time	2011	Stuart G. Baker Daniel J. Sargent Marc Buyse Tomasz Burzykowski	1
+	Safety Analysis in Controlled Clinical Trials	1998	Christy Chuang‐Stein	1
+	Surrogate threshold effect: an alternative measure for meta‐analytic surrogate endpoint validation	2006	Tomasz Burzykowski Marc Buyse	1
+	An Analytical Approach to Assess the Predictive Value of Biomarkers in Phase II Decision Making	2013	Stavros Nikolakopoulos Willem M. van der Wal Kit C. B. Roes	1
+	Meta-analysis for the evaluation of potential surrogate markers	1997	Michael J. Daniels Michael D. Hughes	1
+	Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials	2009	Qian Shi Daniel J. Sargent	1
+	Two simple approaches for validating a binary surrogate endpoint using data from multiple trials	2008	Stuart G. Baker	1
+	Assessing surrogates as trial endpoints using mixed models	2004	Edward L. Korn Paul S. Albert Lisa M. McShane	1
+ PDF Chat	On meta-analytic assessment of surrogate outcomes	2000	Mitchell H. Gail Ruth M. Pfeiffer Hans C. van Houwelingen Raymond J. Carroll	1
+	A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint	2005	Stuart G. Baker	1
+	Surrogate Endpoints in Aids Drug Development: Current Status	1998	Christy Chuang‐Stein Ralph DeMasi	1
+ PDF Chat	The validation of surrogate endpoints in meta-analyses of randomized experiments	2000	Marc Buyse Geert Molenberghs Tomasz Burzykowski Didier Renard Helena Geys	1
+	Advanced methods in meta‐analysis: multivariate approach and meta‐regression	2002	Hans C. van Houwelingen Lidia R. Arends Theo Stijnen	1
+	Statistical evaluation of biomarkers as surrogate endpoints: a literature review	2005	Christopher J. Weir Rosalind Walley	1
+	Statistical validation of intermediate endpoints for chronic diseases	1992	Laurence S. Freedman Barry I. Graubard Arthur Schatzkin	1
+	Surrogate endpoints in clinical trials: Definition and operational criteria	1989	Ross L. Prentice	1
+	Evaluating surrogate markers.	1995	Michael D. Hughes Victor DeGruttola Seth L. Welles	1
+	Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials	2001	Victor G De Gruttola Pamela Clax David L. DeMets Gregory J. Downing Susan S. Ellenberg Lawrence S. Friedman Mitchell H. Gail Ross L. Prentice Janet Wittes Scott L. Zeger	1
+	Hierarchical polytomous regression models with applications to health services research	1997	Michael J. Daniels Constantine Gatsonis	1
+	Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework	2001	Arthur J. Atkinson Wayne A. Colburn Victor G. DeGruttola David L. DeMets Gregory J. Downing Daniel F. Hoth John A. Oates Carl C. Peck Robert T. Schooley Bert Spilker	1